Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
AI is providing emotional support for employees – but is it a valuable tool or privacy threat? - 2Soldiers seize power in Guinea-Bissau and detain the president
- 3Grasping the Course of Evacuation and Extradition in U.S. Migration
- 4A definitive Manual for Picking Electric Vehicle: Decision in favor of Your Number one
- 5Procter & Gamble changes Crest toothpaste packaging to address Texas AG fluoride concerns
- Argentina reportedly delaying embassy move over Israeli company's oil project near Falklands
- Thousands of ultra-orthodox protest in Jerusalem against conscription
- In vogue Sleepwear Patterns for 2024
- Activists Took BMW and Mercedes to Court Over Gas Cars. It Didn’t Stick
- The Best Competitors of the 21st Hundred years
- 2025 among world's three hottest years on record, WMO says
- Vote In favor of Your Favored Kind Of Vegetable
- Viable Correspondence: Building Solid Connections
- South America's Memorable Destinations: A Movement Guide
